Saltar para:
Logótipo
Você está em: Início > Publicações > Visualização > Antipsychotics-induced metabolic alterations: Focus on adipose tissue and molecular mechanisms

Antipsychotics-induced metabolic alterations: Focus on adipose tissue and molecular mechanisms

Título
Antipsychotics-induced metabolic alterations: Focus on adipose tissue and molecular mechanisms
Tipo
Outra Publicação em Revista Científica Internacional
Ano
2015
Autores
Goncalves, P
(Autor)
Outra
A pessoa não pertence à instituição. A pessoa não pertence à instituição. A pessoa não pertence à instituição. Sem AUTHENTICUS Sem ORCID
Martel, F
(Autor)
FMUP
Revista
Vol. 25
Páginas: 1-16
ISSN: 0924-977X
Editora: Elsevier
Outras Informações
ID Authenticus: P-00A-2ZS
Abstract (EN): The use of antipsychotic drugs for the treatment of mood disorders and psychosis has increased dramatically over the last decade. Despite its consumption being associated with beneficial neuropsychiatric effects in patients, atypical antipsychotics (which are the most frequently prescribed antipsychotics) use is accompanied by some secondary adverse metabolic effects such as weight gain, dyslipidemia and glucose intolerance. The molecular mechanisms underlying these adverse effects are not fully understood but have been suggested to involve a dysregulation of adipose tissue homeostasis. As such, the aim of this paper is to review and discuss the rote of adipose tissue in the development of secondary adverse metabolic effects induced by atypical antipsychotics. Data analyzed in this article suggest that atypical antipsychotics may increase adipose tissue (particularly visceral adipose tissue) lipogenesis, differentiation/hyperplasia, proi-nflammatory mediator secretion and insulin resistance and decrease adipose tissue lipolysis. Consequently, patients receiving antipsychotic medication could be at risk of developing obesity, type 2 diabetes and cardiovascular disease. A better knowledge of the impact of these drugs on adipose tissue homeostasis may unveil strategies to develop novel antipsychotic drugs with less adverse metabolic effects and to develop adjuvant therapies (e.g. behavioral and nutritional therapies) to neuropsychiatric patients receiving antipsychotic medication.
Idioma: Inglês
Tipo (Avaliação Docente): Científica
Nº de páginas: 16
Documentos
Não foi encontrado nenhum documento associado à publicação.
Publicações Relacionadas

Dos mesmos autores

Uptake of folates by rat and human brain endothelial cell lines (2010)
Outras Publicações
Araújo JR; Goncalves, P; Martel, F
The effect of cannabinoids on the uptake of 2-deoxy-D-glucose by Caco-2 cells (2008)
Outras Publicações
Goncalves, P; Araújo JR; Azevedo, I; Martel, F
Modulation of folic acid uptake into BeWo cells by cannabinoids (2009)
Outras Publicações
Araújo JR; Goncalves, P; Martel, F
Modulation of folic acid uptake in BeWo cells by cannabinoids (2009)
Outras Publicações
Martel, F; Araújo JR; Goncalves, P

Ver todas (8)

Da mesma revista

Tolerability of outpatient antipsychotic treatment: 36-month results from the European Schizophrenia Outpatient Health Outcomes (SOHO) study (2009)
Artigo em Revista Científica Internacional
Diego Novick; Josep Maria Haro; Elena Perrin; David Suarez; João Marques Teixeira
Effect of chronic methylphenidate treatment on hippocampal neurovascular unit and memory performance in late adolescent rats (2019)
Artigo em Revista Científica Internacional
Coelho Santos, V; Cardoso, FL; Ana Magalhaes; Ferreira Teixeira, M; Leitao, RA; Gomes, C; Rito, M; Barbosa, M; Fontes Ribeiro, CA; Silva, AP
A multi-centre, randomised, double-blind, placebo-controlled clinical trial of methylphenidate in the initial treatment of acute mania (MEMAP study) (2018)
Artigo em Revista Científica Internacional
Hegerl, U; Mergl, R; Sander, C; Dietzel, J; Bitter, I; Demyttenaere, K; Gusmao, R; Arrillaga, AGP; Zorrilla, I; Alocen, AG; Sola, VP; Vieta, E; Juckel, G; Zimmermann, US; Bauer, M; Sienaert, P; Quintao, S; Edel, MA; Bolyos, C; Ayuso Mateos, JL...(mais 2 autores)
Recomendar Página Voltar ao Topo
Copyright 1996-2025 © Faculdade de Medicina Dentária da Universidade do Porto  I Termos e Condições  I Acessibilidade  I Índice A-Z
Página gerada em: 2025-08-22 às 16:34:08 | Política de Privacidade | Política de Proteção de Dados Pessoais | Denúncias | Livro Amarelo Eletrónico